PremiumCompany AnnouncementsJPMorgan Increases Stake in Clarity Pharmaceuticals Clarity Pharmaceuticals Refocuses on High-Priority Cancer Programs JPMorgan Chase & Co. Increases Stake in Clarity Pharmaceuticals PremiumCompany AnnouncementsVanguard Group Becomes Substantial Holder in Clarity Pharmaceuticals Clarity Pharmaceuticals Announces Cessation of Securities JPMorgan Chase Acquires Substantial Stake in Clarity Pharmaceuticals PremiumCompany AnnouncementsClarity Pharmaceuticals Reports Increased Loss but Stronger Asset Base Clarity Pharmaceuticals Secures FDA Fast Track for Prostate Cancer Treatment Clarity Pharmaceuticals’ 64Cu-SAR-bisPSMA Receives FDA Fast Track Designation